Traws Pharma, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRAW and other ETFs, options, and stocks.

About TRAW

Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. 

CEO
Iain David Dukes
CEOIain David Dukes
Employees
7
Employees7
Headquarters
Newtown, Pennsylvania
HeadquartersNewtown, Pennsylvania
Founded
1998
Founded1998
Employees
7
Employees7

TRAW Key Statistics

Market cap
24.09M
Market cap24.09M
Price-Earnings ratio
1.44
Price-Earnings ratio1.44
Dividend yield
Dividend yield
Average volume
205.51K
Average volume205.51K
High today
$1.60
High today$1.60
Low today
$1.50
Low today$1.50
Open price
$1.50
Open price$1.50
Volume
56.65K
Volume56.65K
52 Week high
$3.27
52 Week high$3.27
52 Week low
$0.97
52 Week low$0.97

Stock Snapshot

Traws Pharma, Inc.(TRAW) stock is priced at $1.63, giving the company a market capitalization of 24.09M. It carries a P/E multiple of 1.44.

During the trading session on 2026-05-06, Traws Pharma, Inc.(TRAW) shares reached a daily high of $1.60 and a low of $1.50. At a current price of $1.63, the stock is +8.9% higher than the low and still +1.7% under the high.

Trading volume for Traws Pharma, Inc.(TRAW) stock has reached 56.65K, versus its average volume of 205.51K.

Over the past 52 weeks, Traws Pharma, Inc.(TRAW) stock has traded between a high of $3.27 and a low of $0.97.

Over the past 52 weeks, Traws Pharma, Inc.(TRAW) stock has traded between a high of $3.27 and a low of $0.97.

People also own

Based on the portfolios of people who own TRAW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.